P1.18-01 RELAY EU/US Subset: Ramucirumab Plus Erlotinib Improves Progression-Free Survival in First-Line EGFR Mutation-Positive NSCLC
Aix, S., Novello, S., Garon, E., Nakagawa, K., Nadal, E., Moro-Sibilot, D., Garcia, M. Alonso, Fabre, E., Frimodt-Moller, B., Zimmermann, A., Visseren-Grul, C., Reck, M.Volume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.1317
Date:
October, 2019
File:
PDF, 149 KB
2019